Stock 6949 PELL BIO-MED TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pell Bio-Med Technology Co., Ltd.

Equities

6949

TW0006949001

Biotechnology & Medical Research

End-of-day quote Taiwan S.E.
Other stock markets
 23:00:00 04/07/2024 BST 		5-day change 1st Jan Change
130 TWD -1.52% Intraday chart for Pell Bio-Med Technology Co., Ltd. -4.41% 0.00%
06-17 Pell Bio-Med Technology Co., Ltd.(TWSE:6949) added to Taiwan TAIEX Index CI

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 13.98 17.16 18.03
EBITDA 1 -178.3 -217.4 -392
EBIT 1 -196 -236.1 -411.2
Operating Margin -1,402.03% -1,376.17% -2,280.52%
Earnings before Tax (EBT) 1 -189 -231.3 -401.2
Net income 1 -189 -230.1 -398.8
Net margin -1,351.93% -1,341.32% -2,211.26%
EPS 2 -5.680 -5.870 -8.620
Free Cash Flow - -86.4 -53.62
FCF margin - -503.57% -297.32%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 11/03/24 11/03/24 15/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 19.8 - -
Net Cash position 1 - 506 933
Leverage (Debt/EBITDA) -0.1111 x - -
Free Cash Flow - -86.4 -53.6
ROE (net income / shareholders' equity) - -44.5% -40.2%
ROA (Net income/ Total Assets) - -20.5% -20.9%
Assets 1 - 1,121 1,910
Book Value Per Share 2 6.760 18.10 21.70
Cash Flow per Share 2 3.480 3.890 3.110
Capex 1 14.5 6.5 16.5
Capex / Sales 103.56% 37.86% 91.42%
Announcement Date 11/03/24 11/03/24 15/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PELL BIO-MED TECHNOLOGY CO., LTD. Stock Pell Bio-Med Technology Co., Ltd.
0.00% 229M
MODERNA, INC. Stock Moderna, Inc.
+18.97% 45.34B
LONZA GROUP AG Stock Lonza Group AG
+41.98% 40.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-10.06% 37.92B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+31.15% 31.75B
CELLTRION, INC. Stock Celltrion, Inc.
-7.79% 27.71B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.32% 26.52B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+43.05% 13.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.28% 12.44B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-7.41% 11.26B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6949 Stock
  4. Financials Pell Bio-Med Technology Co., Ltd.